EPGL Company info 08/31/2014 00:22:38 $EPGL I remember

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
EPGL Company info 08/31/2014 00:22:38 $EPGL
I remember that- third law of thermodynamics stuffs.

Epgl
When you got some of the best talent in the world assembled into a company with the worlds largest accounting firm and insiders controlling the O/S that's the 1st sign of legit, then you look at zero toxic debt, zero dilution, real technology 2nd sign legit, next we have filling showing a major development agreement with a top lens manufacturer & distributer COO that is sign 3 this is legit and confirms EPGL as valid and legit. Now if some continue to argue EPGL is a scam, well to say it nicely they look silly!
Lmfaorotff as they would say lol

$$$$ EPGL $$$$

EPGL Stock Message Board http://investorshangout.com/EP-Global-Communi...PGL-87206/

Thanks Viking for all your posts and encouragement
throughout the last years. People have told me to sell
but I just kept doing more DD and now I have accumulated
over 2 million shares and told countless people . My friend
who trades stock everyday told me yesterday that I was
right all along when he doubted all the time. Now
he's investing Tuesday. Go Epgl
From last August...I think EPGL & COO are further along in development then most of us realize.

Quote:
We now have the ability to use MEMS to put the technology into the micro size environment for contact lenses. This technology will be incorporated into therapeutic contact lenses which will emit a low, safe dose of the ultrasound energy into the eye on a regular basis for the purpose of slowing or arresting the development of macular degeneration, retinitis pigmentosa and other eye disorders," said David T. Markus, PhD. "We want to pioneer the area of therapeutic contact lenses and we can see a tremendous market size and need going into the future for this technology."



About David T. Markus, Ph.D. Vice President - BioMems Development

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery. Finally, Dr. Markus is fluent in English, Chinese-Madarin, Taiwanese-FuJian and Indonesian languages.





The contact lens market is huge market, make them smart and this market will grow 10-fold, best part is Cooper now leads the race as EPGL advanced technology has given them the only self contained self powered source of energy, they now have the technology to bring these lenses to market!

EPGL is leading giants, make no mistake about it!

$$$ EPGL $$$

$$$ COO $$$$
Not only does EPGL have a confirmed deal with COO, they are in discussions with other major players in consumer electronics!!

We could be talking Apple, Google, Samsung, Amazon and many others in future deals!


If they can make a deal in this sector, this will be much bigger than contact lens deal, imho. That will be huge. Google, apple, Facebook comes in mind.

Let's see. I am excited.

Epgl
Also, EPGL is currently in discussions with more than one major company to secure rights to its technologies in the consumer electronics and communications field


I agree. I am wondering what some of those folks, who said Epgl a scam in this board before, are thinking now. Looks like they missed the opportunity to buy in cheap, imho.

Epgl
Just one of Coopers products could mean billions in future sales, YES BILLIONS, this means huge revenues for both COO & EPGL!


EPGL is supplying the technology for these advanced products, what happens when we see licensing agreements to other major companies put in place?

EPGL is much more then a .077 OTC stock, soon we will be trading .10+, then work towards .25+ in time DOLLARS

$$$$ EPGL $$$$
Right. That was back in the days of the MPDD and muscle pain treatment devices. Obviously the MPDD is still being manufactured, marketed and sold.

With the much more recent tech I see no reason why this isn't a 50-100 billion company in 3-5 years. So yeah, I'm calling it: $10-$20 a share in 3-5 years. Mark this post.
Absolutely right. There are some of us longs that have been EPGL Shareholders for 4-5+ years now. If 100's of thousands in swings in a single day, week, month or year haven't made us sell yet, guess what these small movements won't any time soon.
There are hundreds of millions held long that will stay that way for years yet in my very strong opinion.
EPGL will be a life changer for customers and shareholders alike.
THIS IS NOT A PINKSHEET COMPANY. It is just a short entry level buying opportunity of a future blue chip.

Quote:
L2 hasn't been perfect for this stock. With the expectations held by the longs on this board 1-2cents doesn't bother us (the majority at least). With multiple $s on the way what's the difference between $1.20 and $1.22? Only $16000 for me out of a total of ~$850000. I'd rather not risk waiting for a dip and missing the run.

From all that's been said it's safe to say the product is near completion with coo. With the added bonus of additional partners within a short period of time by September next year we'll be at $1+. Probably sooner if you take into account ray kurzweils 'Singularity' and the timeline the future holds based in the past thousands of years. It's all out there to study.

Sometime back in one of the CCs , ceo said, he would value epgl at $2 if this was a private company. That was way before the valuation of Epgl's current IPs and of course these current developments. I am wondering what valuation is he thinking now.

This can be a life changing opportunity for longs, imho. Time will tell. Glad to be a shareholder from 2009-2010.

Epgl
Time to get in EPGL is before this deal is more widely exposed to analysts, EPGL was .082 before close and painted .077 to close. Trend is clearly up wayyyyy up, just look at chart. EPGL will break past .10 next week in my strong opinion. I have had good response from big time money players they will find a spot


Retrace to .10 coming, find your spot before big money takes it higher, much higher, know what you own With EPGL

$$$$$ EPGL $$$$$$
$EPGL
#COO
#MEMS

September is going to be a month filled with "Holy shit!" and "yee-haaa!"... okay and the occasional "WTF!"
EPGL
"Like"
That's what people were saying at .02. Everything about this company is legit.

Yes, there could be some slight consolidation. Keep in mind the majority of the float is held by Long Term shareholders with no plans to sell anything. Additionally, there was so much selling leading up to the news, that the small dip we had due to the selling on the news, had no steam to take down to anything noteworthy. With the expected news on the 4th and analyst conference on the 11th, plus any unpredictable news, it's not likely that the stock will see any retracting movement that can sustain anything under .07.
Soon EPGL breaks .10 then the move up much higher, this little drop reset chart, very strong. My buy order is in for Tuesday morning, accumulating EPGL is good for you.


$EPGL
I did as well
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Humberto Quintanar Strengthens McKinley Irvin's Seattle Team

Updated Category News Views 46

Humberto Quintanar Makes His Move In a world where legal battles can shake lives to the core, McKinley Irvin is throwing another heavyweight into the ring. They’ve just pulled in Humberto Quintanar, a guy who knows his way around a courtroom like a cabbie knows a city's backstreets. This isn't just another seat-fillin' lawyer; Quintanar packs years of experience as a...

Continue Reading
Approved Oil Secures Long-Term NYC Fuel Terminal Deal

Updated Category News Views 94

Approved Oil Locks in Future with Sunoco Deal Amidst the contraction of New York City's fuel terminal landscape, securing a consistent lifeline to crucial infrastructure feels like striking gold. Approved Oil just locked down an agreement with Sunoco for a new terminal location that'll last deep into the 2040s, and it's about more than just securing a spot on the...

Continue Reading
Columbia Distributing Expands to Alaska: A Growth Move

Updated Category News Views 33

Alaska's Entry: Columbia's New Frontier When Columbia Distributing dives into a new territory, you know they're serious about growth. This latest move sees them planting their flag in Alaska, finally completing a strategic vision that's been brewing for a while. Four-State Strategy Comes to Fruition The transaction with Republic National Distributing Company (RNDC) is no...

Continue Reading
Gildan's Troubling Legal Struggles: Investor Action Alert

Updated Category News Views 60

Gildan's Bumpy Ride: Legal Woes Unfold Well, folks, seems like Gildan Activewear Inc. (NYSE:GIL) is in for a bumpy ride, and not the kind that makes you feel alive, I tell ya. They've been slapped with a class action lawsuit, and the news ain't pretty. Accusations are flying hot about how they've been playing fast and loose with their financials. The Allegations: Channel...

Continue Reading
DropGenie Nets $5M to Boost Functional Biology Reach

Updated Category News Views 109

DropGenie Scores Big with Fresh Financing Boost Out of the Montreal wilderness, DropGenie is charging forward with a fresh $5 million injection in Seed+ financing. This isn't just loose change; it's a ticket to accelerating their mission of advancing functional biology platforms and beefing up data partnerships. You know, the kind of partnerships that even the suits in...

Continue Reading
Skechers Facing Class Action: Investors Urged to Act

Updated Category News Views 0

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Continue Reading
Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Updated Category News Views 0

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Continue Reading
Ernesta Expands Southeast Reach with Atlanta Showroom

Updated Category News Views 85

Ernesta's Southeast Play: The Atlanta Showroom Here's something to turn heads in the world of custom home design—Ernesta has just set up shop in Atlanta, a move that speaks volumes about their ambitions in the Southeast market. This isn't just about selling a few more rugs; it's a calculated step into a region ripe with design potential and a hunger for bespoke home...

Continue Reading
Gildan Activewear Faces Major Class Action Lawsuit

Updated Category News Views 126

Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...

Continue Reading
Bertram Capital Backs MCE's Expansive Growth Vision

Updated Category News Views 92

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Opportunities at the 2026 China Clean Expo

Updated Category News Views 158

Welcome to the China Clean Expo 2026 The 27th China Clean Expo (CCE) is set to take place from March 31 to April 3, 2026, at the Shanghai New International Expo Center. This event, organized by IM Sinoexpo with support from notable associations, including ISSA, promises to be a hub for industry leaders, innovators, and solution providers in the cleaning sector. The...

Continue Reading
Magellan Health and Calm Health Collaboration Enhances Support

Updated Category News Views 372

Magellan Health Partners with Calm Health Magellan Health, Inc. is excited to announce a new partnership with Calm Health, aimed at providing improved mental health support for its members. This collaboration is designed to streamline the process for individuals seeking help, ensuring they receive the necessary resources in a timely manner. Understanding the Importance of...

Continue Reading
Celebrating the Visionaries: 2025 Franklin Institute Laureates

Updated Category News Views 3874

Honoring Global Innovators Across Science and Business The Franklin Institute is set to celebrate the exceptional contributions of its 2025 Franklin Institute Laureates. This illustrious occasion recognizes pioneers who have made significant advancements in science, technology, and business leadership. Among the nine distinguished honorees are trailblazers like Muyinatu...

Continue Reading
Origin Investments Launches Innovative 1031 Exchange Program

Updated Category News Views 267

Origin Investments Enters the 1031 Exchange Market Origin Investments has marked a significant milestone by completing its first acquisition under the newly established Origin Exchange program, which focuses on Delaware Statutory Trust (DST) investments. The company has acquired The Starling, a modern multifamily community featuring 300 recently developed units,...

Continue Reading
Tenaris Sees Growth Amid Challenges in Q2 2025 Financials

Updated Category News Views 263

Tenaris Reports Second Quarter Financial Results for 2025 Tenaris S.A. (NYSE: TS, BMV: TS.MX, Milan: TEN) has released its financial results for the second quarter of 2025, demonstrating resilience in a fluctuating market. Compared to the same period last year, there have been notable changes in performance metrics, illustrating both growth opportunities and challenges...

Continue Reading